Gene · 57154
Papers1,908
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,908
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Matrix-associated extracellular vesicles modulate smooth muscle cell adhesion and directionality by presenting collagen VI. | bioRxiv | 2025 | 37645762 | PubTator, text mining | PubMed |
| SMURF1/2 Are Novel Regulators of WNK1 Stability. | Kinases Phosphatases | 2024 | 40895768 | PubTator, text mining | PubMed |
| SMURF1 and SMURF2 directly target GLI1 for ubiquitination and proteasome-dependent degradation. | Cell Death Discov | 2024 | 39695131 | PubTator, text mining | PubMed |
| E3 Ubiquitin Ligase Smurf1 Regulates the Inflammatory Response in Macrophages and Attenuates Hepatic Damage during Betacoronavirus Infection. | Pathogens | 2024 | 39452742 | PubTator, text mining | PubMed |
| Exosomal non-coding RNAs: Emerging insights into therapeutic potential and mechanisms in bone healing. | J Tissue Eng | 2024 | 39371940 | PubTator, text mining | PubMed |
| HSPA12A stimulates "Smurf1-Hif1α-aerobic glycolysis" axis to promote proliferation of renal tubular epithelial cells after hypoxia/reoxygenation injury. | Cell Stress Chaperones | 2024 | 39349238 | PubTator, text mining | PubMed |
| Correction: Dong et al. Smurf1 Suppression Enhances Temozolomide Chemosensitivity in Glioblastoma by Facilitating PTEN Nuclear Translocation. Cells 2022, 11, 3302. | Cells | 2024 | 39329781 | PubTator, text mining | PubMed |
| Serum Iron Overload Triggers the SMAD Pathway and Induces Hepcidin Expression in Hepatocytes through SMURF1. | J Clin Transl Hepatol | 2024 | 39280070 | PubTator, text mining | PubMed |
| METTL14-Mediated m6A Modification of TUG1 Represses Ferroptosis in Alzheimer's Disease via Inhibiting GDF15 Ubiquitination. | Front Biosci (Landmark Ed) | 2024 | 39206905 | PubTator, text mining | PubMed |
| E3 ubiquitin ligases SMURF1 and HECW1 regulate hepcidin-induced degradation of ferroportin in HeLa cells. | Biochim Biophys Acta Mol Cell Res | 2024 | 39117288 | PubTator, text mining | PubMed |
| SLC14A1 and TGF-β signaling: a feedback loop driving EMT and colorectal cancer metachronous liver metastasis. | J Exp Clin Cancer Res | 2024 | 39061061 | PubTator, text mining | PubMed |
| Correction for: The p53/miR-17/Smurf1 pathway mediates skeletal deformities in an age-related model via inhibiting the function of mesenchymal stem cells. | Aging (Albany NY) | 2024 | 38902894 | PubTator, text mining | PubMed |
| AMPK induces PIAS3 mediated SUMOylation of E3 ubiquitin ligase Smurf1 impairing osteogenic differentiation and traumatic heterotopic ossification. | Biochim Biophys Acta Mol Cell Res | 2024 | 38844181 | PubTator, text mining | PubMed |
| Smurf1-targeting microRNA-136-5p-modified bone marrow mesenchymal stem cells combined with 3D-printed β-tricalcium phosphate scaffolds strengthen osteogenic activity and alleviate bone defects. | Kaohsiung J Med Sci | 2024 | 38820598 | PubTator, text mining | PubMed |
| The genetic landscape of autism spectrum disorder in the Middle Eastern population. | Front Genet | 2024 | 38572415 | PubTator, text mining | PubMed |
| GSG2 promotes thyroid cancer via stabilizing AURKB and activating AKT pathway. | Aging (Albany NY) | 2024 | 38441546 | PubTator, text mining | PubMed |
| Smurf1 Modulates Smad Signaling Pathway in Fibrotic Cataract Formation. | Invest Ophthalmol Vis Sci | 2024 | 38324299 | PubTator, text mining | PubMed |
| The E3 ligase SMURF1 stabilizes p27 via UbcH7 catalyzed K29-linked ubiquitin chains to promote cell migration SMURF1-UbcH7 K29 ubiquitination of p27 and cell migration. | J Biol Chem | 2024 | 38301893 | PubTator, text mining | PubMed |
| The scaffold protein AXIN1: gene ontology, signal network, and physiological function. | Cell Commun Signal | 2024 | 38291457 | PubTator, text mining | PubMed |
| Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives. | Mol Cancer | 2024 | 38262996 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57154/papers?page=5